Medifast, Inc.
MED
$12.57
$0.171.37%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -186.15% | -992.97% | -96.61% | -87.60% | -110.33% |
| Total Depreciation and Amortization | 13.51% | 12.08% | 8.44% | 4.67% | -4.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.74% | 8.62% | -95.90% | -88.78% | 65.91% |
| Change in Net Operating Assets | -54.28% | -0.62% | 40.56% | -74.63% | -106.20% |
| Cash from Operations | -81.96% | -71.96% | -81.99% | -93.17% | -77.33% |
| Capital Expenditure | 27.29% | 24.68% | -7.08% | -2.69% | -14.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.96% | 87.86% | -35.51% | 94.05% | 66.37% |
| Cash from Investing | 10.82% | 70.11% | -25.75% | 84.14% | 58.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -97.22% | -100.00% | -100.00% | -100.00% |
| Repurchase of Common Stock | -110.05% | 55.74% | 56.09% | 60.86% | 58.68% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 55.78% | 72.73% | 98.96% | 99.47% | 99.64% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -53.66% | 62.77% | 97.09% | 98.49% | 98.94% |
| Foreign Exchange rate Adjustments | -87.50% | -91.49% | 100.00% | 103.13% | 148.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -250.85% | 53.73% | -717.41% | 83.95% | 78.10% |